{"cmr":"ca-cm-kg/TSXV/NTLX","since":null,"total":26,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-10-22","event_type":"newswire_release","title":"NeuroThera Labs Reports Positive Progress in FDA ...","wire":"TheNewswire","source":"TheNewswire","url":"https://www.thenewswire.com/press-releases/1BKRFazqD-neurothera-labs-reports-positive-progress-in-fda-approved-phase-iib-clinical-trial-for-tourette-syndrome.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"mQ3hKABgiZoDRV_2IyYfKG8fttsqfnj2p_o_iERSNn5xuXUUuCZ5CJVu7mc2NpL4hfYGFusuSHC0p_TFU9KiBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-10-22","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs Reports Positive","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/22/3386394/0/en/scisparc-subsidiary-neurothera-labs-reports-positive-progress-in-fda-approved-phase-iib-clinical-trial-for-tourette-syndrome.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"X9dw5eicf0ydThKwQYC7NZTY5v9OXjOBhQR7SuSuVc6FepO4cRuXsAAxAizbJbC9jTfS8a6WKQb0_YYy68mcBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-10-07","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/07/3376445/0/en/scisparc-subsidiary-neurothera-labs-cliniquantum-reports-successful-quantum-enabled-analysis-of-billions-of-gene-combinations-using-real-world-clinical-data-on-an-s-p-500-company-s.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_kzpAUJCBT1PTRX5pmlmURXcQqMxMhfMSXlZb_FucCQng1_LipCM13GPGovyyYOxY_gjKgqW5_318nszCGaJBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-09-23","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Highlights Enhancement of","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/23/3367467/0/en/scisparc-subsidiary-neurothera-highlights-enhancement-of-u-s-patent-portfolio-through-collaboration-with-clearmind-covering-lsd-ketamine-and-ibogaine-combinations.html","read_by":"Tavily search (wire domains) + published_date","state":"sourced","detail":"matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'; matched on distinctive token 'neurothera'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Icp2PfHQ3SgaL3GB5FGZIcmaALR5IhbQZsNnos2KaRTDYCcx_gHVrqFpOL9bnNMmNfVRm6K8WJDN7ksgiKnsCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-09-02","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/02/3355122/0/en/scisparc-subsidiary-neurothera-labs-pursues-fda-orphan-drug-designation-for-adult-tourette-syndrome-drug-engages-government-and-public-affairs-firm-rk-strategies.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"QP_QCJ8ltC0i6mM9SBu06WIqk1LAuiauEAWGRGn6Nun_vtGwpju7hsMk_LMIU_36ea8lcWTrszBbVDKq5BnECw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-08-31","event_type":"corporate_action","title":"TSXV bulletin: CONSOLIDATION WITHOUT A NAME CHANGE (Constating Documents)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=321000&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Constating Documents / CONSOLIDATION WITHOUT A NAME CHANGE","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9_uLb4QCixm6MIm3i0F91KXoCLghyk8J0QdIlW5c9odX0LeqTigGm2gMXRKpWUQDbrI2l77LH6THgQPFq5WXBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-08-31","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs Achieves Significant","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/08/31/3353674/0/en/scisparc-subsidiary-neurothera-labs-achieves-significant-enrollment-momentum-in-sci-210-autism-clinical-trial.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"d9wISbempXq6SijFfJ0H54jG9JwW0mq1kc1N4tzGzf2MQ9gr8ksQj-FHRjszrZ3Ini6Y-0Hne_YJFVj7PgL0BA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-08-27","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=320953&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"gMkfwbktlhKSxNLycpjeH67Ob6yesqsqMdfV6jO1nr0U4j75K9r60Bdk3oKR8LWx1W6pf1u8k6UVAEHSEstUBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-08-18","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/08/18/3346796/0/en/scisparc-subsidiary-neurothera-labs-completes-c-5-4-million-financing-with-scisparc-s-stake-valued-at-approximately-c-30-million.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"fuFAfBDTLbe5VZAj82R9ZKew1dH186d5yeUt5Z5okdD1_bR26534tHGQmqA-g-izEdAlBCL0pIpn1EhMuJ-ECQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-08-05","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/08/05/3339281/0/en/SciSparc-Subsidiary-NeuroThera-Labs-Launches-Phase-IIb-Clinical-Trial-at-Yale-Child-Study-Center-for-First-of-its-kind-Treatment-for-Tourette-Syndrome.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZfjtElln78jZWeBnayRWVrYsZK232ORxD-NtdUBY2FgbSmNplGHcg14WgrL_jRIIpFnBiXNjNox9fUdMem5GDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-07-31","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/07/31/3336768/0/en/SciSparc-Subsidiary-NeuroThera-Labs-Quantum-Platform-Demonstrates-Complete-End-to-End-Hybrid-Quantum-Classical-Workflow-for-Clinical-Data-Analytics.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"lVNA92co_1sL8nsLFVWOsost4Yd1_jK4zP_bcLipUEHX6Eb5xiFPKv2VExFtWCO3sqluvItyxztwdWm6EKqyCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-07-29","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/07/29/3335231/0/en/SciSparc-Subsidiary-NeuroThera-Labs-Advances-its-Quantum-Platform-for-Clinical-Data-Analytics-on-a-Platform-of-an-S-P-500-company.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"OPeMIBvmm8kxBG2jqBYc_003_CjaT0jKiHtth9dVmG26wI59Hd5sFtwEacFm2VIgL_LWKqAAoRhbEVE7njT9Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-07-15","event_type":"newswire_release","title":"SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/07/15/3327736/0/en/scisparc-neurothera-labs-announces-initiation-of-phase-iib-clinical-trial-at-hannover-medical-school-in-germany-for-innovative-treatment-of-tourette-syndrome.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"aUvKVxJfRtDhi8H-kNP6bzeVkAwccPs7eqdwx4Db8lQBi4ejXgfKhTbMOjkdHjRMuRvuwshJ793gqAKUhK3cBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-06-04","event_type":"exchange_bulletin","title":"TSXV bulletin: PROPERTY-ASSET OR SHARE PURCHASE AGREEMENT (Property Transaction)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=318574&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Property Transaction / PROPERTY-ASSET OR SHARE PURCHASE AGREEMENT","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1OsT1tN6wfB2lp-rJBslqSmes9nm1F-97frp1CgZAXmZfo6VMq9eNhDcILKpKOmBMsYhLYP84bvUaTxE6TtqCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-06-04","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/06/04/3306664/0/en/SciSparc-Subsidiary-NeuroThera-Labs-Completed-Acquisition-of-CliniQuantum.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"fWMBJBzEDxeLkJaWVD-cDFV0QVjIo-FYgqsq4HwQ7jUKGRh84MHJZt905ixec4XlVHNfLnn2Sy9itHFvZd6SAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-05-28","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/05/28/3302879/0/en/SciSparc-Subsidiary-NeuroThera-Labs-Received-Conditional-Regulatory-Approval-for-Acquisition-of-CliniQuantum.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Td6pKdb0fTlCWEegQeN3FTvE8fTXRzRqpSKAxvLN4Cx699e6qBrvWhcNUsoyJaXFK1qAXn5B1g71Eju_Z8vtDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-03-16","event_type":"newswire_release","title":"SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/03/16/3256253/0/en/SciSparc-NeuroThera-Labs-Clearmind-Medicine-Collaboration-Leads-to-Patent-Application-for-Depression-Therapy.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"VwrabnieEq6_vV_SPaKEZhPmv5v5gouo_74L0b7WsFz7zVFNfk9YJGSa_vn1yz3nD0-zmZDuzffyaeWhEUc6CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-03-12","event_type":"newswire_release","title":"SciSparc: NeuroThera Labs Announces Publication of","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/03/12/3254524/0/en/SciSparc-NeuroThera-Labs-Announces-Publication-of-International-Patent-in-Collaboration-with-Clearmind-Medicine-for-Novel-Therapy-Targeting-Weight-Loss-and-Fatty-Liver-Disease.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Ph5fzUnQOJXxbn6CNBZ1N3Ro0U_wBTIwqlzQ4h5-99OXu6gAuvl5l3_mpj3fiGcgRWbyq9oBfwMWXNuwHQBYAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-03-10","event_type":"newswire_release","title":"SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/03/10/3252980/0/en/SciSparc-Subsidiary-NeuroThera-Labs-75-Signs-Definitive-Agreement-to-Acquire-Majority-Stake-in-CliniQuantum-Innovator-in-Quantum-based-Clinical-trails.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"CMZFWxdnj72IBlrb5gBsZVo-y9G9PL3C6idyv2X4T8lfTOgfB14OKOcKgo9IFcL0krNentwMd-Endd8EiFHHCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2026-02-02","event_type":"newswire_release","title":"SciSparc: NeuroThera Labs Granted U.S. Patent for","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/02/02/3230254/0/en/scisparc-neurothera-labs-granted-u-s-patent-for-cannabinoid-technology-to-overcome-antimicrobial-resistance-such-as-mrsa.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"sQzCct2XMol8uKY3aN3MLXxEpg4i-Tn8IDgkZcdiWtI3dgrgzgXgwNZyO-NF2iUNXQL10P0Ebr4bQeSi2OMbAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2025-12-30","event_type":"newswire_release","title":"SciSparc: Neurothera Labs Granted Patent by Israeli Patent","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/12/30/3211377/0/en/SciSparc-Neurothera-Labs-Granted-Patent-by-Israeli-Patent-Office-for-its-Proprietary-Opioid-Based-Patent-Family-to-Enhance-Pain-Relief-and-Reduce-Side-Effects.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-TbXHEiOeK8kSEFS36endpkAgQIvWOkthwlaRkddLkc1M6LaW-BeYsLnMfBoJUAwn39tNeB54GunRCPQi3odCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2025-12-02","event_type":"newswire_release","title":"SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/12/02/3198102/0/en/SciSparc-Neurothera-Labs-Signs-Non-Binding-Term-Sheet-to-Acquire-Majority-Stake-in-a-Quantum-Algorithm-Bio-Data-Analysis-Company.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"kfdR3W9EK8l65-ZkYu0iffiPXwD8cV9S8dOWnaGsm9kzjiQJP4xJGRW2OK-cqFp-zU1DeiV1HoWp_K-lk1HhAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2025-11-20","event_type":"newswire_release","title":"SciSparc: Neurothera Labs Announces Israeli Patent","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/20/3191728/0/en/SciSparc-Neurothera-Labs-Announces-Israeli-Patent-Application-in-Collaboration-with-Clearmind-Medicine-for-Novel-Non-Hallucinogenic-Neuroplastogen-Treatment-for-Depression.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2w4xvDfPP-Qbxvo-NUZkwjjZkSXAFCxl-X7bsenst0qUXY8Fkw0-nSSjTs9AbtYcCedyHg4Cj87hOlUqeh7zAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2025-10-23","event_type":"corporate_action","title":"TSXV bulletin: NAME CHANGE (Constating Documents)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=304907&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Constating Documents / NAME CHANGE","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XRFsfbcs-C3c7BQmqL0V4wL6X7Hlb9y66nedAE1MrqqMpGz05oENHiruCQLdTf52wGZlodT6dZSDsNyIDEBsDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2025-10-23","event_type":"exchange_bulletin","title":"TSXV bulletin: QUALIFYING TRANSACTION-COMPLETED/NEW SYMBOL (Conditional Listings)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=304907&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Conditional Listings / QUALIFYING TRANSACTION-COMPLETED/NEW SYMBOL","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"D146SXN6SLlcpWbq7A0i_60-COOTtYElX4lgDoVZxnf2RfgVGKUfLrwFfirxDUjC2k8SAEIsNMAV_YlHj9NGCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NTLX","date":"2025-10-23","event_type":"halt_resume","title":"TSXV bulletin: RESUME TRADING (Trading Status)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=304907&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Trading Status / RESUME TRADING","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5zWekHMyDJqaHNaEvRmuzX7YaZXKhLD7DklfoQZIKFD01FhFJXTuie7-WaBam5DiNuHu8xtrH4_bfhq6H3kiAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}